Literature DB >> 9242526

Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.

R K Rathbun1, G R Faulkner, M H Ostroski, T A Christianson, G Hughes, G Jones, R Cahn, R Maziarz, G Royle, W Keeble, M C Heinrich, M Grompe, P A Tower, G C Bagby.   

Abstract

Hematopoietic progenitor cells (HPC) from mice nullizygous at the Fanconi anemia (FA) group C locus (FAC -/-) are hypersensitive to the mitotic inhibitory effects of interferon (IFN-gamma). We tested the hypothesis that HPC from the bone marrow of Fanconi group C children are similarly hypersensitive and that the fas pathway is involved in affecting programmed cell death in response to low doses of IFN-gamma. In normal human and murine HPC, IFN-gamma primed the fas pathway and induced both fas and interferon response factor-1 (IRF-1) gene expression. These IFN-gamma-induced apoptotic responses in HPC from the marrow of a child with FA of the C group (FA-C) and in FAC -/- mice occurred at significantly lower IFN doses (by an order of magnitude) than did the apoptotic responses of normal HPC. Treatment of FA-C CD34+ cells with low doses of recombinant IFN-gamma, inhibited growth of colony forming unit granulocyte-macrophage and burst-forming unit erythroid, while treatment with blocking antibodies to fas augmented clonal growth and abrogated the clonal inhibitory effect of IFN-gamma. Transfer of the normal FAC gene into FA-C B-cell lines prevented mitomycin C-induced apoptosis, but did not suppress fas expression or inhibit the primed fas pathway. However, the kinetics of Stat1-phosphate decay in IFN-gamma-treated cells was prolonged in mutant cells and was normalized by transduction of the normal FAC gene. Therefore, the normal FAC protein serves, in part, to modulate IFN-gamma signals. HPC bearing inactivating mutations of FAC fail to normally modulate IFN-gamma signals and, as a result, undergo apoptosis executed through the fas pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242526

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  Impaired function of Fanconi anemia type C-deficient macrophages.

Authors:  Ying Liu; Kimberly Ballman; Deqiang Li; Shehnaz Khan; Ethel Derr-Yellin; Weinian Shou; Laura S Haneline
Journal:  J Leukoc Biol       Date:  2011-11-21       Impact factor: 4.962

2.  Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice.

Authors:  Yue Si; Samantha Ciccone; Feng-Chun Yang; Jin Yuan; Daisy Zeng; Shi Chen; Henri J van de Vrugt; John Critser; Fre Arwert; Laura S Haneline; D Wade Clapp
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

Review 3.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 4.  Mouse models of Fanconi anemia.

Authors:  Kalindi Parmar; Alan D'Andrea; Laura J Niedernhofer
Journal:  Mutat Res       Date:  2009-04-10       Impact factor: 2.433

5.  Natural gene therapy in monozygotic twins with Fanconi anemia.

Authors:  Anuj Mankad; Toshiyasu Taniguchi; Barbara Cox; Yassmine Akkari; R Keaney Rathbun; Lora Lucas; Grover Bagby; Susan Olson; Alan D'Andrea; Markus Grompe
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

6.  MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.

Authors:  Y Li; H Youssoufian
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

7.  Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1.

Authors:  Khadijeh Bijangi-Vishehsaraei; M Reza Saadatzadeh; Adam Werne; Kristina A Wilson McKenzie; Reuben Kapur; Hidenori Ichijo; Laura S Haneline
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

8.  Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.

Authors:  Asmin Tulpule; M William Lensch; Justine D Miller; Karyn Austin; Alan D'Andrea; Thorsten M Schlaeger; Akiko Shimamura; George Q Daley
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

Review 9.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

10.  Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.

Authors:  Michael D Milsom; Bernhard Schiedlmeier; Jeff Bailey; Mi-Ok Kim; Dandan Li; Michael Jansen; Abdullah Mahmood Ali; Michelle Kirby; Christopher Baum; Leslie J Fairbairn; David A Williams
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.